Gregory A. Rippon, MD, MS
Advertisement
Chief medical partner of neurology, ophthalmology, and internal medicine at Genentech
Articles by Gregory A. Rippon, MD, MS
The chief medical partner of neurology, ophthalmology, and internal medicine at Genentech shared his perspective on the steps the field has taken to improve clinical trials and therapies for neurodegenerative diseases such as Alzheimer disease. [WATCH TIME: 3 minutes]
Advertisement
Latest Updated Articles
Applying two decades of Alzheimer’s research and doing what’s right for patientsPublished: September 22nd 2022 | Updated:
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
FDA Approves New Intrathecal Administration Route for Spinal Muscular Atrophy Gene Therapy
2
GLP-1 Semaglutide Fails to Outperform Placebo in Phase 3 EVOKE Trial of Alzheimer Disease
3
Study Identifies Environmental Risk Factors Significantly Associated With Neuromyelitis Optica Spectrum Disorder
4
Advancing DM1 and DMD Care: Insights on DYNE-101 and DYNE-251 Development
5
